• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Using immunohistochemistry, fluorescence in situ hybridization and RNAscope to analyze the status of PD-L1 in multiple cancers].

作者信息

Xia L H, Pu X H, Fu Y, Wei J, Fan X S

机构信息

Department of Pathology, Gaochun People's Hospital Branch, the Affiliated Drum Tower Hospital, Nanjing University Medical School, Gaochun 211300, China.

Department of Pathology, the Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, China.

出版信息

Zhonghua Bing Li Xue Za Zhi. 2020 Nov 8;49(11):1183-1186. doi: 10.3760/cma.j.cn112151-20200702-00521.

DOI:10.3760/cma.j.cn112151-20200702-00521
PMID:33152828
Abstract
摘要

相似文献

1
[Using immunohistochemistry, fluorescence in situ hybridization and RNAscope to analyze the status of PD-L1 in multiple cancers].
Zhonghua Bing Li Xue Za Zhi. 2020 Nov 8;49(11):1183-1186. doi: 10.3760/cma.j.cn112151-20200702-00521.
2
About PD-L1 Immunohistochemistry and RNA In Situ Hybridization in Lung Adenocarcinoma.关于肺腺癌中程序性死亡受体配体1（PD-L1）免疫组织化学和RNA原位杂交
Appl Immunohistochem Mol Morphol. 2019 Jan;27(1):e9-e10. doi: 10.1097/PAI.0000000000000640.
3
Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma.EGFR、ALK或ROS1中经典驱动癌基因突变与肺腺癌中22C3-PD-L1≥50%表达之间的相关性
J Thorac Oncol. 2017 May;12(5):878-883. doi: 10.1016/j.jtho.2016.12.026. Epub 2017 Jan 16.
4
Concordance levels of PD-L1 expression by immunohistochemistry, mRNA in situ hybridization, and outcome in lung carcinomas.免疫组织化学、mRNA 原位杂交检测 PD-L1 表达的一致性水平及其与肺癌预后的关系。
Hum Pathol. 2018 Dec;82:282-288. doi: 10.1016/j.humpath.2018.07.025. Epub 2018 Jul 31.
5
Programmed death-ligand-1 expression in advanced gastric cancer detected with RNA in situ hybridization and its clinical significance.RNA原位杂交检测晚期胃癌中程序性死亡配体-1的表达及其临床意义
Oncotarget. 2016 Jun 28;7(26):39671-39679. doi: 10.18632/oncotarget.9381.
6
Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer.非小细胞肺癌中PD-L1和PD-L2拷贝数增加的临床意义
Oncotarget. 2016 May 31;7(22):32113-28. doi: 10.18632/oncotarget.8528.
7
PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.PD-L1 和 PD-L2 在原发性皮肤弥漫性大 B 细胞淋巴瘤，腿型中由巨噬细胞或肿瘤细胞差异表达。
Am J Surg Pathol. 2018 Mar;42(3):326-334. doi: 10.1097/PAS.0000000000000983.
8
Diagnostic Utility of PD-L1 Expression in Lung Adenocarcinoma: Immunohistochemistry and RNA In Situ Hybridization.PD-L1表达在肺腺癌中的诊断效用：免疫组织化学和RNA原位杂交
Appl Immunohistochem Mol Morphol. 2018 Sep;26(8):e86-e90. doi: 10.1097/PAI.0000000000000595.
9
PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer.两种互补诊断检测方法及mRNA原位杂交在小细胞肺癌中PD-L1的表达
J Thorac Oncol. 2017 Jan;12(1):110-120. doi: 10.1016/j.jtho.2016.09.002. Epub 2016 Sep 14.
10
PD-L1 expression is associated with massive lymphocyte infiltration and histology in gastric cancer.程序性死亡受体配体1（PD-L1）表达与胃癌中的大量淋巴细胞浸润及组织学相关。
Hum Pathol. 2016 Sep;55:182-9. doi: 10.1016/j.humpath.2016.05.012. Epub 2016 May 31.